How to Evaluate an RCM AI Partner and Verify Real Outcomes

Every RCM vendor today says the same thing. “AI-powered.” “Intelligent automation.” “Predictive denial prevention.” The words repeat across nearly every proposal a healthcare CFO reads, and they rarely mean the same thing twice. Meanwhile, the financial pressure on revenue cycle teams keeps building, and outsourcing is growing rather than shrinking. That combination puts finance leaders in a tough spot. They need a partner that can prove results. This guide walks through a practical framework for that evaluation. It starts with the numbers you need before you even open an RFP, moves through the benchmarks a real AI partner should clear, the questions vendors hope you never ask, a scorecard for judging the technology itself, and the contract terms that make proof enforceable rather than promised.

Why Healthcare RCM Has Become a CFO-Level Priority

For years, revenue cycle management sat quietly in the back office, treated as a cost center to be trimmed rather than a lever for financial health. That view is outdated. Margin pressure from inflation, staffing shortages, and rising labor costs has pushed RCM into the center of the CFO’s strategic agenda. The regulatory environment has made this pressure sharper. H.R.1, signed into law on July 4, 2025, adds new financial pressure through changes to Medicaid financing and eligibility. More than 65% of surveyed RCM leaders anticipate negative financial impact from this legislation alone. Layer on the No Surprises Act and hospital price transparency rules, and the compliance overhead on top of collections has grown substantially. The financial signals point in one direction.

• 50% of leaders expect payment denials to increase
• 56% foresee an increase in days in accounts receivable
• 76% expect self-pay bad debt and uncompensated care to rise
• 85% anticipate a bigger share of costs shifting to patients out of pocket

Meanwhile the cost to collect keeps climbing. 45% of organizations across all sizes report rising collection costs, and smaller organizations (under $500 million in net patient service revenue) feel it more than larger ones (above $5 billion), at 44% versus 33%.

How Payer Delays Are Driving Up RCM Costs

A large share of the friction sits outside the provider’s own walls. 78% of leaders say at least 10% of their A/R lengthening traces directly back to payer causes such as pending records, disputed authorizations, or appeal backlogs. Escalated reimbursement issues take an average of 36 days to resolve, and only 43% of those escalations end in the provider’s favor.

Where escalations resolve less than 60% of the time, leaders point to slow or asynchronous communication with payers (30%), prior authorization and eligibility friction (21%), and coding disagreements (18%). Clinical denials carry the heaviest cost. On average, 2.63% of net patient service revenue gets written off due to clinical denials. 47% of leaders name clinical denial improvement a top priority, yet only 36% have built standardized prevention processes to address it. That gap between intent and execution is exactly where an outcome-focused RCM partner should be expected to close ground.

Given these pressures, outsourcing is expanding rather than contracting. 60% of leaders plan to change their vendor strategy over the next two years, and 75% of that group are expanding outsourcing. Only 6% plan to reduce outsourcing because of technology. Organizations that hit their RCM targets tend to expand within their current vendor relationships (59%), while those who missed their targets are more likely to go shopping for a new one (68%).

Performance is what earns a vendor more business, more than price alone. This is exactly why the evaluation bar for a new or renewed RCM AI partner needs to be higher than a features list.

Six Baseline Metrics to Collect Before You Evaluate Any RCM Vendor

The most common mistake in RCM partner selection happens before a single vendor call. Organizations sign contracts without an agreed baseline, so there is no way to prove, months later, whether the partner moved the needle at all. Before writing an RFP, pull these six figures from your current operations.

1. Initial denial rate. The share of claims denied by payers on first submission.
2. Overturn rate. The share of appealed denials that get successfully reversed and paid.
3. Time-to-appeal. The median number of days between a denial and a completed appeal.
4. Claim abandonment rate. The share of denied claims written off without ever being appealed.
5. Cost-per-claim rework. The fully loaded internal cost, labor and technology included, to work one denied claim.
6. Net revenue at risk. The dollar value of claims sitting unworked past 60 days.

Write these into the contract itself. The strongest partnership structures tie vendor fees or performance bonuses to documented improvement above this baseline, so both sides are measuring the same starting line.

RCM AI Performance Benchmarks Your Vendor Should Meet

Once you have your baseline, use it against the benchmarks below to separate genuine performance from marketing language.

Metric	Manual workflow baseline	Tech-enabled standard	What a leading AI partner should hit
Overturn rate	35% to 60%	60% or higher	70%+
Time-to-appeal	15 to 30 days	Faster with automation	Under 7 days
Claim abandonment rate	35% to 65%	Lower with standardization	Under 15%
Cost per claim rework	$43.84 average, up to $63.76 for commercial payers	Reduced through automation	Meaningfully below industry average
Minimum workable claim	$3,000 to $5,000 (manual labor floor)	Lower with partial automation	Under $1,000 with true AI appeal drafting

That last row deserves attention. Under manual workflows, the labor cost of pursuing a claim below $3,000 to $5,000 often exceeds what it recovers, so those claims quietly get written off. If a vendor’s automation is real, that floor should drop substantially. If it stays close to the manual number, the “AI” is likely doing less than advertised.

Six RCM Vendor Questions Most RFPs Fail to Ask

Generic RFPs collect generic answers. Almost every vendor will claim AI-powered denial management. Few can answer these questions with specifics.

What is your overturn rate by specific payer and denial type?

A blended average hides weak spots. A vendor that excels at simple coding denials but struggles with complex medical necessity denials carries a different risk profile than one with balanced performance across both.

What is your minimum economically workable claim?

This exposes how much of the work still depends on human labor. If the true floor sits near the manual $3,000 to $5,000 range, smaller claims are still being abandoned quietly, and that is real revenue left on the table.

What happens to your institutional knowledge when your staff turns over?

This is the difference between a scalable technology platform and a staffing agency wearing an AI label. If appeal success depends on a handful of senior specialists, their turnover becomes your risk.

How do you handle timely filing risk?

Payers enforce resubmission deadlines, typically 90 to 180 days for many commercial plans and 12 months for Medicare. If a vendor falls behind, claims can age past those deadlines and become permanently uncollectible. Ask for defined SLAs on accounts approaching deadline, plus clear terms on who bears the loss if they slip.

What is your compliance infrastructure?

RCM operates inside HIPAA, HITECH, and a patchwork of state patient communication laws. Ask for specific certifications, a description of how patient communications get reviewed, and an honest account of past incidents.

Can you operate across the full continuum?

A point solution that only handles denials adds coordination overhead. A true partner should be able to work across denial management, extended business office functions, early-out billing, bad debt recovery, and legal recovery under one operating model.

A 5-Point Scorecard for Evaluating RCM AI Technology

Once a vendor clears the questions above, evaluate the underlying AI on five dimensions, scoring each from 1 to 5.

1. Unified data foundation. Does the platform pull data together across workflows, or does it operate on siloed pockets of information?
2. Embedded AI capabilities. Is AI woven into daily decisions, predicting denial risk and surfacing payer pattern shifts before submission, or is it a reporting layer applied after the fact?
3. Agentic AI maturity. Does the system take multi-step action end to end, reviewing a denial, pulling the medical record, drafting the appeal, and submitting it, or does it stop at generating alerts for a human to act on?
4. Integration depth. How well does it connect to your EHR, practice management system, clearinghouse, and billing platform?
5. Proven, customer-attributable outcomes. Can the vendor show verified results tied to specific clients, or only generic case studies without traceable attribution?

Three areas sit outside the scorecard entirely as non-negotiable gates rather than scored dimensions.

• Auditable trails. Every autonomous AI decision or action needs a clear, permanent record.
• Configurable human-in-the-loop controls. You should be able to set review thresholds by workflow and financial risk. AI drafting appeals without structured human validation creates real compliance exposure.
• End-to-end PHI protection. Coverage from the moment data is ingested through model use and storage, with nothing left implicit.

A vendor that cannot demonstrate all three should not advance in the process, regardless of how the rest of the scorecard looks.

Contract Terms That Hold an RCM AI Partner Accountable

A strong evaluation process only pays off if the contract that follows locks in the same accountability. Banks apply the same discipline when choosing a managed services provider for regulated operations.

1. Write baselines into the agreement. Tie fees or bonuses to improvement above the documented starting numbers instead of a generic promise to “reduce denials.”
2. Protect against timely filing loss. Define clearly who is financially liable if accounts age past resubmission deadlines because of vendor backlog.
3. Guarantee data portability. You should be able to extract your complete claims history, appeals record, and outcome data in a usable format if the relationship ends.
4. Preserve audit rights. Retain the explicit right to review the vendor’s compliance workflows, patient communications, and data security practices on an ongoing basis.
5. Evaluate net yield over unit price. A partner charging $35 per claim with a high overturn rate delivers more net patient revenue than a $25-per-claim vendor with a weak overturn rate. Judge cost per recovered dollar rather than cost per claim worked.
6. Consider a champion-challenger structure. Test a new vendor live, at limited scale, against your incumbent before committing fully. This keeps both sides accountable and reduces the risk of a disruptive full replacement.

Proven Outcomes Are What Separate Real RCM AI Partners From the Rest

Every item above points back to one theme. In a regulated environment, AI earns trust through what it can prove rather than what it promises. Auditable decisions, human oversight at the right thresholds, and outcomes tied to real client data are the same standards that matter across regulated industries facing AI adoption, from banking to insurance to healthcare. At Anaptyss, this is the operating principle behind how we build and govern AI for regulated operations. Domain expertise sets the context, AI handles the scale, and human oversight keeps every decision accountable and auditable. For revenue cycle leaders evaluating their next AI partner, proof over promises is the real differentiator to look for.

Frequently Asked Questions

1. What metrics should I baseline before choosing an RCM AI vendor?
   Capture your initial denial rate, overturn rate, time-to-appeal, claim abandonment rate, fully loaded cost per reworked claim, and net revenue sitting unworked beyond 60 days. Writing these baselines into the contract lets both sides measure improvement from the same starting line.
2. How can I tell whether an RCM vendor’s AI is real?
   Ask for overturn rates by payer and denial type, the minimum economically workable claim, and results attributable to named clients. If the smallest claim a vendor can profitably pursue sits close to the manual floor of $3,000 to $5,000, much of the work is still manual.
3. Which contract terms protect providers in RCM outsourcing?
   Tie fees or bonuses to documented improvement over baseline, assign liability for timely filing losses caused by vendor backlog, guarantee full data portability, preserve audit rights over compliance workflows, and consider a champion-challenger structure before moving all volume to a new vendor.